Hawkins (HWKN) Earnings Date & Reports

Key Takeaways

• Hawkins reported fiscal second-quarter revenue of $313.8 million, up 11.9% year over year and above the consensus estimate of roughly $302.7 million.
• Diluted earnings per share (EPS, or profit divided by shares outstanding) rose 24.1% to $1.34, topping analyst expectations of $1.19 to $1.22.
• Net income climbed 23% to $27.8 million, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) increased 16% to $59.1 million.
• The Water Treatment segment led growth, with revenue up 16% to $175.0 million on higher volumes and improved pricing.
• The balance sheet strengthened, with the leverage ratio improving to 1.22x trailing twelve-month adjusted EBITDA from 1.37x at fiscal year-end 2026.
• For more details on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore these additional pages.
• To discover AI-driven trading strategies across the broader market, explore Trending AI Robots.

Earnings Context and Why It Matters

Hawkins, Inc. is a specialty chemicals and water treatment company whose fiscal year ends in late March, meaning this report covers its fiscal 2027 second quarter, which ended September 27, 2026. The quarter matters because it tests whether Hawkins can keep growing after a heavy stretch of acquisitions, particularly in Water Treatment, without sacrificing profitability. In the prior quarter the company missed EPS estimates, so investors were watching closely for a return to execution. A record quarter in revenue, gross profit, EPS, and adjusted EBITDA suggests the company's higher-margin water treatment strategy is gaining traction and offsetting softer conditions in food-related end markets.

Reported Results

Hawkins delivered revenue of $313.8 million for its fiscal second quarter, an 11.9% increase from $280.4 million a year earlier and above the analyst consensus of about $302.7 million. Organic growth, which excludes acquired businesses, was roughly 11%.

Diluted EPS reached $1.34, up 24.1% from $1.08 in the prior-year quarter and ahead of the consensus range of $1.19 to $1.22. Net income rose 23% to $27.8 million, while gross profit climbed 13% to $76.6 million and operating income advanced 23% to $41.9 million. Adjusted EBITDA increased 16% to $59.1 million from $50.9 million.

By segment, Water Treatment revenue grew 16% to $175.0 million, driven by increased volumes and improved pricing. Food & Health Sciences rose 5% to $76.7 million, and Industrial Solutions increased 10% to $62.2 million. On the balance sheet, total debt stood at $229.0 million with a leverage ratio of 1.22x trailing twelve-month adjusted EBITDA, down from 1.37x at the end of fiscal 2026.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF (exchange-traded fund) discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to uncover opportunities aligned with your own research approach.

Market Reaction and Investor Sentiment

Shares of Hawkins moved sharply higher after the release, rising roughly 10% to 12% in after-hours trading as investors rewarded the broad-based beat. The positive reaction marked a contrast with the prior quarter, when a modest EPS miss contributed to a decline. Sentiment improved on the combination of stronger-than-expected revenue and EPS, double-digit Water Treatment growth, and better-than-anticipated leverage, which together signaled that recent acquisitions are being integrated without eroding profitability.

Forward Outlook and Key Factors to Monitor

Hawkins enters the second half of its fiscal year with momentum, but several factors will shape the path ahead. Investors are likely to watch whether Water Treatment can sustain double-digit growth as acquisition contributions lap and organic volumes remain the primary driver.

Margin trends will also be in focus. Food & Health Sciences posted lower gross profit in the quarter, and management has previously flagged pricing pressures in food end markets. A continued recovery in that segment would support consolidated profitability.

Balance sheet execution is another key variable. The company repurchased $12 million of stock, paid down $15 million of debt, and completed an acquisition during the quarter, and management has targeted a leverage ratio of approximately 1x adjusted EBITDA by the end of fiscal 2027. Further debt reduction and disciplined capital allocation will be watched closely.

Finally, broader dynamics such as raw material costs, tariff-related impacts, and demand in industrial and municipal water treatment markets could influence results in coming quarters. Investors will look for management's guidance and commentary on these themes in the earnings call and subsequent quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations